Tag - pharmaceuticals

 
Menu
Search
 
September 12, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Takeda Pharmaceutical’s experimental narcolepsy drug shows significant improvement in late-stage trials, potentially targeting the root cause of the disorder.
JAPAN / Science & Health
Sep 9, 2025
Takeda nears first therapy for root cause of narcolepsy
Patients who took the drug, called oveporexton, for 12 weeks experienced increased daytime alertness and an overall improvement in quality of life.
A staff member works in the lab of Hobum Oleochemicals, a manufacturer that develops sustainable chemical raw materials derived from renewable plant oils, in Hamburg, Germany, on Aug. 25.
BUSINESS / Markets
Sep 4, 2025
Trump's tariffs threaten to choke European chemicals recovery
The sector has been grappling in recent years with high production costs after gas and power prices soared following Russia's invasion of Ukraine.
A partly-used, 10 gram bag of semaglutide powder made by China-based Sinopep-Allsino Biopharmaceutical, at a compounding pharmacy in Arlington, Virginia, in December 2024.
BUSINESS / Companies
Sep 3, 2025
Chinese companies turn to generics as patents expire on weight-loss drugs
U.S. regulators have restricted the sale of cheap copies of the drugs, slowing demand for raw ingredients Chinese firms supplied over the past two years.
Aska Pharmaceutical's emergency contraceptive pill Norlevo
JAPAN / Science & Health
Aug 31, 2025
Japan panel OKs nonprescription sales of morning-after pill
The panel also agreed that the product will be classified as a drug that must be taken in the presence of a trained pharmacist for safety reasons.
The health ministry is considering allowing nationwide pharmacy sales of emergency contraceptive pills without requiring age restrictions or parental approval.
JAPAN / Science & Health
Aug 28, 2025
Japan weighs OTC sales of emergency contraceptive pills without age limit
To ensure proper use, the plan would require that the morning-after pill be taken in the presence of a pharmacist.
Chugai Pharmaceutical shares sank as much as 20% in Tokyo on Friday after a study revealed that an obesity drug it licensed to Eli Lilly & Co. resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
BUSINESS / Companies
Aug 8, 2025
Chugai stock drops the most since 1977 on disappointing obesity drug data
A study showed the drug, which it has licensed to Eli Lilly & Co., resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
The price of Alzheimer's drug Lecanemab, codeveloped by Japanese drugmaker Eisai and U.S. industry peer Biogen, will be lowered to ¥97,277 for a 500-milligram bottle.
JAPAN / Science & Health
Aug 7, 2025
Japan approves price cut for Alzheimer's drug Lecanemab
The drug's price will be lowered to ¥97,277 for a 500-milligram bottle starting on Nov. 1.
Sumitomo Pharma applied to Japanese regulators for manufacturing and marketing authorization aimed at treating patients with advanced Parkinson's disease.
JAPAN / Science & Health
Aug 5, 2025
Drugmaker in Japan seeks approval for stem cell treatment for Parkinson's
A trial led by Kyoto University researchers indicated treatment using induced Pluripotent Stem cells was safe and successful in improving symptoms of the disease.
The newly developed drug, Adriana, is a groundbreaking painkiller, which works on a completely different mechanism to morphine and other existing synthetic opioids.
JAPAN
Aug 5, 2025
Kyoto University team develops pain reliever comparable to morphine
Morphine, often administered to cancer patients, can cause serious adverse effects such as breathing issues and addiction.
Kobayashi Pharmaceutical Chairman Yoshihito Ota speaks during an interview in Osaka last month.
BUSINESS / Companies
Aug 4, 2025
Kobayashi Pharmaceutical chairman vows corporate culture reform
Kobayashi Pharmaceutical achieved net profit growth for over 20 years from its stock market listing until the beni kо̄ji scandal emerged last year.
U.S. President Donald Trump steps on stage to deliver remarks at the Salute to America Celebration at the Iowa State Fairgrounds in Des Moines on July 3.
BUSINESS / Economy
Jul 19, 2025
Trump aims tariff double whammy at industries and nations by Aug. 1
In addition to measures on copper, the U.S. has discussed making announcements on lumber, chips, critical minerals and drugs, in that order, though this may change.
Researchers at the National Cancer Center Japan say a new type of gut bacteria named YB328 could help unlock the potential of cancer immunotherapy.
JAPAN / Science & Health
Jul 15, 2025
Japan researchers identify gut bacteria strain that boosts anticancer drugs
The discovery may help raise the success rate of a type of cancer treatment that currently works for only 20% of patients who receive it.
One of the early exemplars of Chinese innovation is a cell therapy that has shown promise to potentially cure a deadly blood cancer.
BUSINESS / Tech
Jul 14, 2025
China biotech’s stunning advance is changing the world’s drug pipeline
The number of novel drugs in China entering into development ballooned to over 1,250 last year, far surpassing the European Union.
The Astellas Pharma headquarters in Tokyo. A district court in Beijing will hand down a ruling on Wednesday for a Japanese employee of Astellas Pharma, who has been charged with espionage in China, according to sources.
JAPAN / Crime & Legal
Jul 11, 2025
Chinese court to issue ruling on Japanese businessman
While the Japanese employee of Astellas Pharma was indicted in August last year, the Chinese side has not disclosed details of his charges.
The health ministry is expected to cut the official price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai and Biogen of the United States, by up to 15% from the current level of about ¥3 million per patient a year.
JAPAN / Science & Health
Jul 10, 2025
Japan to cut price of Alzheimer's drug lecanemab
The health ministry is expected to cut the official price of the drug by up to 15% from the current level of about ¥3 million per patient a year.
U.S. President Donald Trump (center) with Secretary of State Marco Rubio (left) and Defense Secretary Pete Hegseth at the White House on Tuesday
BUSINESS / Markets
Jul 9, 2025
Trump vows no tariff extension and hardens threats on copper and drugs
The U.S. president stresses he would not offer additional extensions on country-specific levies set to now hit in early August.
In an effort to move past its troubled legacy, Kobayashi Pharmaceutical has replaced its president twice and appointed an external chairman.
BUSINESS / Companies / FOCUS
Jul 8, 2025
Despite leadership changes, Kobayashi Pharma still struggling with reform
The Osaka-based company has replaced its president twice and appointed an external chairman, seeking to reduce the influence of the founding family seen as a cause of the scandal.
Medipal is expanding into areas such as animal health products and drug development as margins from selling pharmaceuticals become squeezed in Japan.
BUSINESS / Companies
Jul 1, 2025
Medipal seeks to diversify amid falling drug margins
Japan’s largest drug wholesaler is seeking to boost profit, excluding extraordinary items, to ¥100 billion by March 2027 from ¥65 billion in the latest fiscal year.
Researchers prepare medicine at a laboratory in Nanjing University in Nanjing, in China's Jiangsu province. China's share of global drug development is now nearly 30%.
BUSINESS / FOCUS
Jun 17, 2025
U.S. pharma bets big on China to snap up potential blockbuster drugs
Firms bet they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.
Intermediary support is crucial for drug availability in Japan, where more than 50 therapies have been identified as needed but unavailable to patients.
BUSINESS / Companies
Jun 5, 2025
Itochu working to support overseas pharma firms to fill Japan's drug gaps
Two units of the trading house will assist with everything from early-stage consulting, regulatory advice and clinical testing support to post-launch distribution.
Workers say corporate South Korea was warned about questionable U.S. visas before Hyundai raid
Activists holding signs that reads "No one is illegal!" protest against a huge immigration raid last week in the U.S. state of Georgia, in front of the U.S. Embassy in Seoul on Tuesday.
As Manila modernizes its military, new opportunities emerge for Tokyo
A Brahmos missile system is displayed during a rehearsal for a military parade in New Delhi in January. The Philippines will soon receive its second batch of the supersonic cruise missiles from India.
Thousands without power in Tokyo as heavy rain batters Kanto region
Heavy rain hit Tokyo and surrounding areas Thursday afternoon, causing thousands to lose power, prompting flood warnings, grounding flights and causing transportation issues.
Why more hotels in Japan are offering room-only service
Nipponia Hotel Ise Kawasaki Merchant Town in Ise, Mie Prefecture
Japan's cutting-edge railgun successfully strikes target vessel
The Defense Ministry’s Acquisition, Technology & Logistics Agency (ATLA) conducted a ship-board railgun shooting test from June to early July this year with the support of the Maritime Self-Defense Force.
Niinami’s ouster quick but not unusual as corporations protect reputation
Takeshi Niinami resigns as chairman and CEO of Suntory Holdings.
As Manila modernizes its military, new opportunities emerge for Tokyo
A Brahmos missile system is displayed during a rehearsal for a military parade in New Delhi in January. The Philippines will soon receive its second batch of the supersonic cruise missiles from India.
Shizuoka farmers fight to preserve sustainable tea method that’s steeped in tradition
As of August 2024, the number of confirmed chagusaba farmers had fallen to 302, just over half the 582 reported in 2015, according to the Shizuoka Chagusaba Farming Method Promotion Council.
Search is on for loopholes in Japan’s $550 billion investment pledge
U.S. Secretary of Commerce Howard Lutnick argues that U.S. President Donald Trump has sole authority to invest Japan's promised $550 billion.
In rural Hokkaido, the stops and starts of tourism revival on full display
Redevelopment plans for Kawayu Onsen have hit some snags — an example of how bringing tourists back to declining rural communities is far from easy work.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Figure skater Akiko Suzuki was once told her ideal weight should be 47 kilograms, a number she now admits she “naively believed.” This led to her have a relationship with food that resulted in her suffering from anorexia.
The silent battle Japanese athletes fight with weight
By Mai Yoshikawa

SUSTAINABLE JAPAN

Foreign wrestlers have a long history in sumo
Foreign wrestlers have a long history in sumo

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER